Zenas BioPharma (ZBIO) Amortizatization of Intangibles (2025 - 2026)
Zenas BioPharma (ZBIO) recorded quarterly Amortizatization of Intangibles of -$110000.0 in Q1 2026, up 73.87% quarter-over-quarter from -$421000.0 in Q4 2025, and up 71.2% on a YoY basis from -$64250.8 in Q1 2025.
Zenas BioPharma (ZBIO) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
Zenas BioPharma's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$110000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 71.2% year-over-year to -$110000.0; the TTM figure through Mar 2026 stood at -$1.7 million (changed N/A YoY), while the FY2025 annual figure was -$1.9 million, down 220.76% from the prior year.
- Amortizatization of Intangibles was -$110000.0 for Q1 2026 at Zenas BioPharma, up from -$421000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of -$110000.0 in Q1 2026 to a low of -$935000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | -110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110,000.00 |
| Mar 31, 2026 | -110,000.00 |
| Dec 31, 2025 | -421,000.00 |
| Dec 31, 2025 | -421,000.00 |
| Sep 30, 2025 | -193,000.00 |
| Sep 30, 2025 | -193,000.00 |
| Jun 30, 2025 | -935,000.00 |
| Jun 30, 2025 | -935,000.00 |
| Mar 31, 2025 | -382,000.00 |
| Mar 31, 2025 | -382,000.00 |